Torii Pharmaceutical Co Ltd
TSE:4551

Watchlist Manager
Torii Pharmaceutical Co Ltd Logo
Torii Pharmaceutical Co Ltd
TSE:4551
Watchlist
Price: 4 435 JPY 0.68% Market Closed
Market Cap: 127.7B JPY
Have any thoughts about
Torii Pharmaceutical Co Ltd?
Write Note

Torii Pharmaceutical Co Ltd
Effect of Foreign Exchange Rates

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Torii Pharmaceutical Co Ltd
Effect of Foreign Exchange Rates Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Effect of Foreign Exchange Rates CAGR 3Y CAGR 5Y CAGR 10Y
Torii Pharmaceutical Co Ltd
TSE:4551
Effect of Foreign Exchange Rates
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Takeda Pharmaceutical Co Ltd
TSE:4502
Effect of Foreign Exchange Rates
-ÂĄ17.1B
CAGR 3-Years
N/A
CAGR 5-Years
20%
CAGR 10-Years
N/A
Daiichi Sankyo Co Ltd
TSE:4568
Effect of Foreign Exchange Rates
-ÂĄ33.3B
CAGR 3-Years
N/A
CAGR 5-Years
-32%
CAGR 10-Years
N/A
Otsuka Holdings Co Ltd
TSE:4578
Effect of Foreign Exchange Rates
-ÂĄ20.7B
CAGR 3-Years
N/A
CAGR 5-Years
-21%
CAGR 10-Years
N/A
Chugai Pharmaceutical Co Ltd
TSE:4519
Effect of Foreign Exchange Rates
ÂĄ3.2B
CAGR 3-Years
6%
CAGR 5-Years
N/A
CAGR 10-Years
16%
Astellas Pharma Inc
TSE:4503
Effect of Foreign Exchange Rates
-ÂĄ1.2B
CAGR 3-Years
N/A
CAGR 5-Years
42%
CAGR 10-Years
N/A
No Stocks Found

Torii Pharmaceutical Co Ltd
Glance View

Market Cap
124.7B JPY
Industry
Pharmaceuticals

Torii Pharmaceutical Co., Ltd. engages in the manufacturing and marketing of pharmaceutical products. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 560 full-time employees. The company went IPO on 2013-10-01. The Company’s main product categories include oral pruritus improving agents, proteolytic enzyme inhibitors, hyperkalemia improving agents, topical adrenocortical hormones, allergen immunotherapy for cedar pollinosis, allergen immunotherapy for mite allergy, active viable bacterial preparations, uterine contraction inhibitors in premature birth and others. The Company’s main products include Remitch, Riona tablets, Keixalate, Yulinome tablets, Antebate, Locoid, Zefnate, Sida Torengi pollen sublingual solution, Miticure mite sublingual tablet, Biosley, Magcent and others.

Intrinsic Value
3 292.36 JPY
Overvaluation 26%
Intrinsic Value
Price

See Also

Back to Top